A novel tetranucleotide repeat polymorphism within KCNQ1OT1 confers risk for hepatocellular carcinoma

DNA and Cell Biology

Volumn 32, Issue 11, 2013, Pages 628-634

  Wan, Jiao ^a   Huang, Moli ^a   Zhao, Hua ^b   Wang, Chaoqun ^a   Zhao, Xiankun ^a   Jiang, Xinghong ^a   Bian, Shizhong ^a   He, Yan ^a   Gao, Yuzhen ^a  

^a MEDICAL COLLEGE OF SOOCHOW UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1C; KCNQ1 OVERLAPPING TRANSCRIPT 1; LONG UNTRANSLATED RNA; UNCLASSIFIED DRUG;

ADULT; ALLELE; ARTICLE; CANCER RISK; CHINESE; COMPUTER MODEL; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; GENOTYPE PHENOTYPE CORRELATION; HEPATOMA CELL; HETEROZYGOTE; HOMOZYGOTE; HUMAN; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SHORT TANDEM REPEAT;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; BASE SEQUENCE; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; CELL LINE, TUMOR; COMPUTER SIMULATION; CYCLIN-DEPENDENT KINASE INHIBITOR P57; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HOMOZYGOTE; HUMANS; LIVER NEOPLASMS; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; MOLECULAR SEQUENCE DATA; POLYMORPHISM, GENETIC; POTASSIUM CHANNELS, VOLTAGE-GATED; PROTEIN FOLDING;

EID: 84886025386     PISSN: 10445498     EISSN: 15577430     Source Type: Journal    
DOI: 10.1089/dna.2013.2118     Document Type: Article

References (31)

1. Allen, R.C., Graves, G., and Budowle, B. (1989). Polymerase chain reaction amplification products separated on rehydrat-able polyacrylamide gels and stained with silver. Biotechni-ques 7, 736-744. (Pubitemid 19212399)
2. Casper, M., Grunhage, F., and Lammert, F. (2011). Cancer risk in chronic hepatitis B: Do genome-wide association studies hit the mark? Hepatology 53, 1390-1392.
3. Chen, C.J., and Chen, D.S. (2002). Interaction of hepatitis B virus, chemical carcinogen, and genetic susceptibility: multistage hepatocarcinogenesis with multifactorial etiology. Hepatology 36, 1046-1049.
4. Chen, K., Song, F., Calin, G.A., Wei, Q., Hao, X., and Zhang, W. (2008). Polymorphisms in microRNA targets: a gold mine for molecular epidemiology. Carcinogenesis 29, 1306-1311.
5. Chiesa, N., De Crescenzo, A., Mishra, K., Perone, L., Carella, M., Palumbo, O., Mussa, A., Sparago, A., Cerrato, F., Russo, S., Lapi, E., Cubellis, M.V., Kanduri, C., Cirillo Silengo, M., Ric-cio, A., and Ferrero, G.B. (2012). The KCNQ1OT1 imprinting control region and non-coding RNA: new properties derived from the study of Beckwith-Wiedemann syndrome and Silver-Russell syndrome cases. Hum Mol Genet 21, 10-25.
6. Duan, J., Wainwright, M.S., Comeron, J.M., Saitou, N., Sanders, A.R., Gelernter, J., and Gejman, P.V. (2003). Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor. Hum Mol Genet 12, 205-216. (Pubitemid 36204418)
7. El-Serag, H.B. (2012). Epidemiology of viral hepatitis and he-patocellular carcinoma. Gastroenterology 142, 1264-1273.
8. Gao, Y., He, Y., Ding, J., Wu, K., Hu, B., Liu, Y., Wu, Y., Guo, B., Shen, Y., Landi, D., Landi, S., Zhou, Y., and Liu, H. (2009). An insertion/deletion polymorphism at miRNA-122-binding site in the interleukin-1alpha 3¢ untranslated region confers risk for hepatocellular carcinoma. Carcinogenesis 30, 2064-2069.
9. Gruber, A.R., Lorenz, R., Bernhart, S.H., Neubock, R., and Ho-facker, I.L. (2008). The Vienna RNA websuite. Nucleic Acids Res 36, W70-W74.
10. Halvorsen, M., Martin, J.S., Broadaway, S., and Laederach, A. (2010). Disease-associated mutations that alter the RNA structural ensemble. PLoS Genet 6, e1001074.
11. Jin, G., Sun, J., Isaacs, S.D., Wiley, K.E., Kim, S.T., Chu, L.W., Zhang, Z., Zhao, H., Zheng, S.L., Isaacs, W.B., and Xu, J. (2011). Human polymorphisms at long non-coding RNAs (lncRNAs) and association with prostate cancer risk. Carci-nogenesis 32, 1655-1659.
12. Kanduri, C. (2011). Kcnq1ot1: a chromatin regulatory RNA. Semin Cell Dev Biol 22, 343-350.
13. Li, S., Qian, J., Yang, Y., Zhao, W., Dai, J., Bei, J.X., Foo, J.N., McLaren, P.J., Li, Z., Yang, J., Shen, F., Liu, L., Yang, J., Li, S., Pan, S., Wang, Y., Li, W., Zhai, X., Zhou, B., Shi, L., Chen, X., Chu, M., Yan, Y., Wang, J., Cheng, S., Shen, J., Jia, W., Liu, J., Yang, J., Wen, Z., Li, A., Zhang, Y., Zhang, G., Luo, X., Qin, H., Chen, M., Wang, H., Jin, L., Lin, D., Shen, H., He, L., de Bakker, P.I., Wang, H., Zeng, Y.X., Wu, M., Hu, Z., Shi, Y., Liu, J., and Zhou, W. (2012). GWAS identifies novel susceptibility loci on 6p21.32 and 21q21.3 for hepatocellular carcinoma in chronic hepatitis B virus carriers. PLoS Genet 8, e1002791.
14. Lincoln, P.J. (1997). DNA recommendations-further report of the DNA Commission of the ISFH regarding the use of short tandem repeat systems. Forensic Sci Int 87, 181-184. (Pubitemid 27294592)
15. Livak, K.J., and Schmittgen, T.D. (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25, 402-408. (Pubitemid 34164012)
16. McGlynn, K.A., and London, W.T. (2011). The global epidemiology of hepatocellular carcinoma: present and future. Clin Liver Dis 15, 223-243.
17. Mohammad, F., Pandey, R.R., Nagano, T., Chakalova, L., Mondal, T., Fraser, P., and Kanduri, C. (2008). Kcnq1ot1/Lit1 noncoding RNA mediates transcriptional silencing by targeting to the perinucleolar region. Mol Cell Biol 28, 3713-3728. (Pubitemid 351732907)
18. Nakano, S., Murakami, K., Meguro, M., Soejima, H., Higa-shimoto, K., Urano, T., Kugoh, H., Mukai, T., Ikeguchi, M., and Oshimura, M. (2006). Expression profile of LIT1/KCNQ1OT1 and epigenetic status at the KvDMR1 in colo-rectal cancers. Cancer Sci 97, 1147-1154. (Pubitemid 44430639)
19. Paulsen, M., Khare, T., Burgard, C., Tierling, S., and Walter, J. (2005). Evolution of the Beckwith-Wiedemann syndrome region in vertebrates. Genome Res 15, 146-153.
20. Prensner, J.R., and Chinnaiyan, A.M. (2011). The emergence of lncRNAs in cancer biology. Cancer Discov 1, 391-407.
21. Rodriguez, B.A., Weng, Y.I., Liu, T.M., Zuo, T., Hsu, P.Y., Lin, C.H., Cheng, A.L., Cui, H., Yan, P.S., and Huang, T.H. (2011). Estrogen-mediated epigenetic repression of the imprinted gene cyclin-dependent kinase inhibitor 1C in breast cancer cells. Carcinogenesis 32, 812-821.
22. Shen, L.X., Basilion, J.P., and Stanton, V.P., Jr. (1999). Single-nucleotide polymorphisms can cause different structural folds of mRNA. Proc Natl Acad Sci USA 96, 7871-7876. (Pubitemid 29328374)
23. Slaby, O., Bienertova-Vasku, J., Svoboda, M., and Vyzula, R. (2012). Genetic polymorphisms and microRNAs: new direction in molecular epidemiology of solid cancer. J Cell Mol Med 16, 8-21.
24. Tanaka, M., Katayama, F., Kato, H., Tanaka, H., Wang, J., Qiao, Y.L., and Inoue, M. (2011). Hepatitis B and C virus infection and hepatocellular carcinoma in China: a review of epidemiology and control measures. J Epidemiol 21, 401-416.
25. Wan, Y., Kertesz, M., Spitale, R.C., Segal, E., and Chang, H.Y. (2011). Understanding the transcriptome through RNA structure. Nat Rev Genet 12, 641-655.
26. Wapinski, O., and Chang, H.Y. (2011). Long noncoding RNAs and human disease. Trends Cell Biol 21, 354-361.
27. Whittaker, S., Marais, R., and Zhu, A.X. (2010). The role of signaling pathways in the development and treatment of hepa-tocellular carcinoma. Oncogene 29, 4989-5005.
28. Xue, Y., Wang, M., Kang, M., Wang, Q., Wu, B., Chu, H., Zhong, D., Qin, C., Yin, C., Zhang, Z., and Wu, D. (2013). Association between lncrna PCGEM1 polymorphisms and prostate cancer risk. Prostate Cancer Prostatic Dis 16, 139-144.
29. Zhang, H., Zhai, Y., Hu, Z., Wu, C., Qian, J., Jia, W., Ma, F., Huang, W., Yu, L., Yue, W., Wang, Z., Li, P., Zhang, Y., Liang, R., Wei, Z., Cui, Y., Xie, W., Cai, M., Yu, X., Yuan, Y., Xia, X., Zhang, X., Yang, H., Qiu, W., Yang, J., Gong, F., Chen, M., Shen, H., Lin, D., Zeng, Y.X., He, F., and Zhou, G. (2010a). Genome-wide association study identifies 1p36.22 as a new susceptibility locus for hepatocellular carcinoma in chronic hepatitis B virus carriers. Nat Genet 42, 755-758.
30. Zhang, X., Rice, K., Wang, Y., Chen, W., Zhong, Y., Nakayama, Y., Zhou, Y., and Klibanski, A. (2010b). Maternally expressed gene 3 (MEG3) noncoding ribonucleic acid: isoform structure, expression, and functions. Endocrinology 151, 939-947.
31. Zhu, Z., Gao, X., He, Y., Zhao, H., Yu, Q., Jiang, D., Zhang, P., Ma, X., Huang, H., Dong, D., Wan, J., Gu, Z., Jiang, X., Yu, L., and Gao, Y. (2012). An insertion/deletion polymorphism within RERT-lncRNA modulates hepatocellular carcinoma risk. Cancer Res 72, 6163-6172.